Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SI | P14410 | 1/20 | 0.36 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5141802 | 0.90 | ALOX15 (0.31) | — | |
| SCHEMBL21847370 | 0.87 | ALDH1A1 (0.36) | ALDH1A1TSHRTHRB | |
| SCHEMBL21847341 | 0.80 | GAA (0.37) | GAAALDH1A1TSHRTHRBLMNA | |
| SCHEMBL27752748 | 0.79 | ALDH1A1 (0.38) | ALDH1A1TSHRTHRB | |
| SCHEMBL27634434 | 0.79 | CYP2D6 (0.32) | TSHRLMNA | |
| SCHEMBL2961856 | 0.73 | MGAM (0.33) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL21858450 | 0.72 | TSHR (0.33) | TSHRTHRB | |
| SCHEMBL28156278 | 0.72 | HCAR2 (0.47) | ALDH1A1TSHRTHRB | |
| SCHEMBL27726505 | 0.71 | HPGD (0.31) | TSHR | |
| SCHEMBL10556760 | 0.69 | ALOX15 (0.31) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0086473-B2 | COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS | Montedison S.p.A. (IT) | 1992-11-11 | — | — | EP | claimed |
| JP-63208597-A | — | — | None | — | — | JP | disclosed |
| EP-1735352-B1 | LATENT, HIGH-ACTIVITY OLEFIN METATHESIS CATALYSTS CONTAINING AN N-HETEROCYCLIC CARBENE LIGAND | CALIFORNIA INST OF TECHN (US) | 2019-08-21 | — | — | EP | disclosed |
| US-9238709-B2 | Latent, high-activity olefin metathesis catalysts containing an N-heterocyclic carbene ligand | MATERIA, INC. (US) | 2016-01-19 | — | — | US | disclosed |
| EP-1391476-B1 | PHOTOREACTIVE COMPOSITION | SEKISUI CHEMICAL CO LTD (JP) | 2015-12-09 | — | — | EP | disclosed |
| US-20150141603-A1 | LATENT, HIGH-ACTIVITY OLEFIN METATHESIS CATALYSTS CONTAINING AN N-HETEROCYCLIC CARBENE LIGAND | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-05-21 | — | — | US | disclosed |
| US-8871879-B2 | Latent, high-activity olefin metathesis catalysts containing an N-heterocyclic carbene ligand | MATERIA, INC. (US) | 2014-10-28 | — | — | US | disclosed |
| US-20130296511-A1 | LATENT, HIGH-ACTIVITY OLEFIN METATHESIS CATALYSTS CONTAINING AN N-HETEROCYCLIC CARBENE LIGAND | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2013-11-07 | — | — | US | disclosed |
| US-7312013-B2 | Photoreactive composition | SEKISUI CHEMICAL CO., LTD. (JP) | 2007-12-25 | — | — | US | disclosed |
| EP-1735352-A2 | LATENT, HIGH-ACTIVITY OLEFIN METATHESIS CATALYSTS CONTAINING AN N-HETEROCYCLIC CARBENE LIGAND | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2006-12-27 | — | — | EP | disclosed |
| WO-2006024885-A1 | PROCESS FOR THE PREPARATION OF POLYISOCYANATE/POLYSILICIC ACID BASED POLYADDITION AND HYBRID RESINS USING BLOCKED POLYISO-CYANATES AND BLOCKED POLYISOCYANATES USABLE IN THE PROCESS | POLINVENT FEJLESZTO, KIVITELEZO ÉS ÉRTÉKESÍTO KFT (HU) | 2006-03-09 | — | — | WO | disclosed |
| US-20050261451-A1 | Latent, high-activity olefin metathesis catalysts containing an N-heterocyclic carbene ligand | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2005-11-24 | — | — | US | disclosed |
| WO-2005094345-A2 | LATENT, HIGH-ACTIVITY OLEFIN METATHESIS CATALYSTS CONTAINING AN N-HETEROCYCLIC CARBENE LIGAND | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2005-10-13 | — | — | WO | disclosed |
| US-20040202956-A1 | a photocurable mixture of a hydrolyzable metal (silyl) compound and a reaction, polymerization or crosslinking promoter; curing; adhesives, seals, semiconductors, dielectrics, microlenses, optical fibers, color filters, gas permeable films | SEKISUI CHEMICAL CO., LTD. (JP) | 2004-10-14 | — | — | US | disclosed |
| EP-1391476-A1 | PHOTOREACTIVE COMPOSITION | SEKISUI CHEMICAL CO., LTD. (JP) | 2004-02-25 | — | — | EP | disclosed |
| US-4904628-A | Components and catalysts for the polymerization of olefins | MONTEDISON S.P.A. (IT) | 1990-02-27 | — | — | US | disclosed |
| JP-S63208597-A | DICHLORO-2-ALKYL-1, 3-DIAMINOPROPANE PLATINUM(II) | TAISHO PHARMACEUT CO LTD | 1988-08-30 | — | — | JP | disclosed |
| US-4522930-A | REACTION PRODUCT OF METALOORGANIC COMPOUND OF ALUMINUM, ELECTRON-DONOR COMPOUND REACTIVE WITH MAGNESIUM CHLORIDE AND A SOLID HALOGENATED TITANIUM COMPOUND | MONTEDISON S.P.A. (IT) | 1985-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261451-A1 | Latent, high-activity olefin metathesis catalysts containing an N-heterocyclic carbene ligand | CDK8, LTC4S, ZCCHC8 | MGAM 1298/4885GAA 3970/4885SI 3028/4885 |
| US-20130296511-A1 | LATENT, HIGH-ACTIVITY OLEFIN METATHESIS CATALYSTS CONTAINING AN N-HETEROCYCLIC CARBENE LIGAND | CDK8, LTC4S, ZCCHC8 | MGAM 1298/4885GAA 3970/4885SI 3028/4885 |
| US-20150141603-A1 | LATENT, HIGH-ACTIVITY OLEFIN METATHESIS CATALYSTS CONTAINING AN N-HETEROCYCLIC CARBENE LIGAND | CDK8, LTC4S, ZCCHC8 | MGAM 1298/4885GAA 3970/4885SI 3028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.